You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Triple Negative Breast Neoplasms

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple-negative Breast Cancer Trial (Taxane and Carboplatin, Short-term Sintilimab, Surgery)

Not yet recruiting
  • Triple-negative Breast Cancer
  • Taxane and Carboplatin
  • +2 more
  • (no location specified)
Apr 25, 2023

Metastatic Malignant Tumor in the Bone, Stage IV Breast Cancer AJCC v6 and v7, Triple-Negative Breast Carcinoma Trial in

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Bone
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 4, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma Trial in Duarte (drug, biological, other)

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Metastatic Triple-Negative Breast Carcinoma
  • Los Angeles, California
    Cedars-Sinai Medical Center
Jan 6, 2023

Triple Negative Breast Cancer Trial (Ociperlimab, Tislelizumab, Paclitaxel)

Not yet recruiting
  • Triple Negative Breast Cancer
  • (no location specified)
Mar 30, 2023

Triple-Negative Breast Cancer Trial in Shanghai (Famitinib, Camrelizumab, nab-Palitaxel/Capecitabine/Eribulin

Not yet recruiting
  • Triple-Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Feb 27, 2023

Triple Negative Breast Cancer Trial in Beijing (Eribulin Mesylate, Lobaplatin)

Recruiting
  • Triple Negative Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Sep 15, 2022

Precision Neoadjuvant Triple-negative Breast Cancer Treatment

Recruiting
  • Triple Negative Breast Cancer
  • Triple Negative Breast Neoplasms
  • Core needle biopsy
  • London, United Kingdom
    Barts Health NHS Trust
Jun 22, 2022

Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple

Recruiting
  • Triple Negative Breast Cancer
    • New Haven, Connecticut
    • +2 more
    Jan 4, 2023

    Metastatic Triple-negative Breast Cancer, Locally Advanced Triple-negative Breast Cancer Trial in Changsha, Xiangyang (AK117,

    Recruiting
    • Metastatic Triple-negative Breast Cancer
    • Locally Advanced Triple-negative Breast Cancer
    • Changsha, China
    • +1 more
    Sep 8, 2022

    Triple Negative Breast Cancer Metastatic Trial in Milano, Padova (Ceralasertib, Durvalumab, Nab-paclitaxel)

    Recruiting
    • Triple Negative Breast Cancer Metastatic
    • Milano, Italy
    • +1 more
    Jan 16, 2023

    Breast Cancer Trial in Beijing (Pembrolizumab, Paclitaxel, Epirubicin)

    Recruiting
    • Breast Cancer
    • Beijing, Beijing, China
      National Cancer Center/National Clinical Research Center for Can
    Dec 28, 2022

    Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Seoul (exosome and ctDNA evaluation)

    Active, not recruiting
    • Triple Negative Breast Cancer
    • HER2-positive Breast Cancer
    • exosome and ctDNA evaluation
    • Seoul, Korea, Republic of
      Ji-Yeon Kim
    Jul 13, 2023

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

    Recruiting
    • Anatomic Stage I Breast Cancer AJCC v8
    • +5 more
    • Biospecimen Collection
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 28, 2022

    Triple Negative Breast Cancer, Metastatic Breast Cancer Trial in Boston (Pembrolizumab, PVX-410)

    Active, not recruiting
    • Triple Negative Breast Cancer
    • Metastatic Breast Cancer
    • Boston, Massachusetts
    • +2 more
    Dec 21, 2022

    Edema, Erythema, Estrogen Receptor Negative Trial in Houston (Laboratory Biomarker Analysis, Pembrolizumab)

    Active, not recruiting
    • Edema
    • +8 more
    • Laboratory Biomarker Analysis
    • Pembrolizumab
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 23, 2023

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma

    Not yet recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +4 more
    • Biopsy
    • +5 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Feb 14, 2023

    Breast Cancer, Triple Negative Breast Cancer, Dietary Exposure Trial (Control diet (ARM A) or Fasting-Like Approach (FLA, ARM

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Control diet (ARM A) or Fasting-Like Approach (FLA, ARM B)
    • (no location specified)
    Feb 28, 2023

    Triple Negative Breast Cancer Trial in Birmingham ([18F]FMISO-PET with contrast-enhanced MRI)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • [18F]FMISO-PET with contrast-enhanced MRI
    • Birmingham, Alabama
      UAB
    Nov 15, 2022

    Triple Negative Breast Cancer Trial in New York (Merck 3475 Pembrolizumab, Intraoperative radiation therapy (IORT))

    Recruiting
    • Triple Negative Breast Cancer
    • Merck 3475 Pembrolizumab
    • Intraoperative radiation therapy (IORT)
    • New York, New York
      Columbia University Irving Medical Center
    Oct 10, 2022

    Breast Cancer, Ductal Carcinoma, Invasive Breast Carcinoma Trial in Tampa (Talimogene laherparepvec, Paclitaxel)

    Active, not recruiting
    Has Results
    • Breast Cancer
    • +3 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Nov 10, 2022

    Metastatic NSCLC, Metastatic Triple-negative Breast Cancer Trial in Houston (biological, drug, radiation)

    Active, not recruiting
    Has Results
    • Metastatic Non-small Cell Lung Cancer
    • Metastatic Triple-negative Breast Cancer
    • ADV/HSV-tk
    • +3 more
    • Houston, Texas
      Houston Methodist Cancer Center
    Dec 28, 2022

    Triple Negative Breast Cancer Trial in Saint Louis (drug, biological, procedure)

    Recruiting
    • Triple Negative Breast Cancer
    • Saint Louis, Missouri
      Washington University School of Medicine
    Oct 19, 2022

    Breast Cancer Trial in Boston (Atezolizumab, Stereotactic radiosurgery (SRS))

    Active, not recruiting
    • Breast Cancer
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Aug 15, 2022

    Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

    Active, not recruiting
    • Advanced Breast Cancer
    • +2 more
    • Talazoparib Tosylate
    • Stanford, California
      Stanford University Hospitals and Clinics
    Nov 16, 2022

    Triple-Negative Breast Cancer Trial in Shanghai (Camrelizumab plus Famitinib with/without nab-Palitaxel)

    Not yet recruiting
    • Triple-Negative Breast Cancer
    • Camrelizumab plus Famitinib with/without nab-Palitaxel
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center Shanghai, China, 200032
    Jan 2, 2023